The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Angiotensin system inhibitors during induction chemotherapy for esophageal adenocarcinoma: Analysis of survival.
 
Abraham Geller
No Relationships to Disclose
 
Michael Lanuti
Honoraria - Holy Cross Hospital
Research Funding - NIH; NIH; Stand up to Cancer
 
Henning A Gaissert
No Relationships to Disclose
 
Cameron D Wright
No Relationships to Disclose
 
Dean M Donahue
No Relationships to Disclose
 
Harald Ott
No Relationships to Disclose
 
Hui Zheng
No Relationships to Disclose
 
Rebecca Suk Heist
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Abbvie (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Debiopharm Group (Inst); Exelixis (Inst); Incyte (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Roche (Inst)
 
Melin Janardan Khandekar
No Relationships to Disclose
 
Rakesh K. Jain
Leadership - Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; Tekla Life Sciences; XTuit Pharmaceuticals
Stock and Other Ownership Interests - Enlight Biosciences; Ophthotech; SynDevRx; XTuit Pharmaceuticals
Consulting or Advisory Role - Merck; Ophthotech; Pfizer; Sun Pharma; SynDevRx
 
Douglas J Mathisen
Travel, Accommodations, Expenses - It is possible some meetings I've been invited to may have had company sponsorship without my knowledge
 
Ashok Muniappan
No Relationships to Disclose